Hyperinsulinemia is related to erythrocyte phospholipid composition and membrane fluidity changes in obese nondiabetic women

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2912-2918

  Candiloros, Harilaos ^b   Zeghari, Nezha ^b   Ziegler, Olivier ^a   Donner, Mireille ^b   Drouin, Pierre ^b  

^a Ctr Hospitalier Univ de Nancy   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MEMBRANE PHOSPHOLIPID; SPHINGOMYELIN;

ADULT; ARTICLE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FASTING; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MEMBRANE FLUIDITY; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; PHOSPHOLIPIDS; REGRESSION ANALYSIS; SPHINGOMYELINS;

EID: 0029788039     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2912     Document Type: Article

References (58)

1. Seely BL, Olefsky JM. 1993 Potential cellular and genetic mechanisms for insulin resistance in the common disorders of diabetes and obesity. In: Moller DE, ed. Insulin resistance. Chichester Wiley and Sons; 187-251.
2. Garvey WT, Birnbaum MJ. 1993 Cellular insulin action and insulin resistance. Bailliere Clin Endocrinol Metab. 7:785-873.
3. Devynck MA. 1995 Do cell membrane dynamics participate in insulin resistance? Lancet. 345:336-337.
4. Shinitzky M. 1984 Membrane fluidity and cellular functions. In: Shinitzky M, ed. Physiology of membrane fluidity. Boca Raton: CRC Press; 1-53.
5. Beguinot F, Tramontano D, Duilio C, et al. 1985 Alteration of erythrocyte membrane lipid fluidity in human obesity. J Clin Endocrinol Metab. 60:1226-1230.
6. Ciancarelli-Tozzi MG, Tozzi E, Di Giulio A, et al. 1987 Properties of erythrocyte membrane in obese children. Cell Mol Biol. 33:355-362.
7. Ferretti G, Curatola G, Bertoli E, Catassi C, Giorgi PL. 1991 Erythrocyte membrane fluidity and changes in plasma lipid composition: a possible relationship in childhood obesity. Biochem Med Metab Biol. 46:1-9.
8. Yeagle PL. 1989 Lipid regulation of cell membrane structure and function. FASEB J. 3:1833-1842.
9. Clandinin MT, Cheema S, Field CJ, Garg ML, Venkatraman J, Clandinin TR. 1991 Dietary fat: exogenous determination of membrane structure and cell function. FASEB J. 5:2761-2769.
10. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. 1993 The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med. 28:238-244.
11. Vessby B, Tengblad S, Lithell H. 1994 Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia. 37:1044-1050.
12. Goldstein DB. 1984 The effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol. 24:43-64.
13. WHO. 1980 Expert Committee on Diabetes Mellitus: second report. Tech Ser Rep 646. Geneva: WHO.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412-419.
15. Lowry OH, Rosebrough JN, Farr A, Randall JR. 1951 Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265-275.
16. Rose HG, Oklander M. 1965 Improved procedure for extraction of lipids from human erythrocytes. J Lipid Res. 6:428-431.
17. Zlatkis A, Zak B. 1969 Study of new cholesterol reagent. Anal Biochem. 29:143-148.
18. Stolyhwo A, Martin M. 1987 Analysis of lipid classes by HPLC with the evaporative light scattering detector. J Liquid Chromatogr. 10:1237-1253.
19. Miller JJ, Valdes R. 1992 Methods for calculating crossreactivity in immunoassays. J Clin Immunoassay. 15:97-107.
20. Sena A, Rebel G, Bieth R, Hubert P, Waksman A. 1982 Lipid composition in liver and brain of genetically obese (ob/ob), heterozygote (ob/ +) and normal (+ / +) mice. Biochim Biophys Acta. 710:290-296.
21. Bielicki JK, Johnson WJ, Glick JM, Rothblat GH. 1991 Efflux of phospholipid from fibroblasts with normal and elevated levels of cholesterol. Biochim Biophys Acta. 1084:7-14.
22. Forte TM, Bielicki JK, Goth-Goldstein R, Selmek J, McCall MR. 1995 Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res. 36:148-157.
23. Engelmann B, Streich S, Schönthier UM, Richter WO, Duhm J. 1992 Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacylglycerol-rich lipoproteins. Biochim Biophys Acta. 1165:32-37.
24. Popp-Snijders C, Schouten JA, Blitterswijk WJ, Van Der Veen EA. 1986 Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta. 854:31-37.
25. Taskinen MR. 1995 Insulin resistance and lipoprotein metabolism. Curr Opin Lipid. 6:153-160.
26. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR. 1990 Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis. 10:232-239.
27. Hannah JS, Howard BV. 1994 Dietary fats, insulin resistance, and diabetes. J Cardiovasc Risk. 1:31-37.
28. Vessby B. 1995 Nutrition, lipids and diabetes mellitus. Curr Opin Lipidol. 6:3-7.
29. Storlien LH, Pan DA, Kritekos AD, Baur LA. 1993 High fat diet-induced insulin resistance. Lessons and implications from animal studies. Ann NY Acad Sci. 683:82-90.
30. Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. 1987 Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr. 45:443-55.
31. Khuu Thi-Dinh KL, Demarne Y, Nicolas C, Lhuillery C. 1990 Effect of dietary fat on phospholipid class distribution and fatty acid composition in rat fat cell plasma membrane. Lipids. 25:278-283.
32. Marin P, Darin N, Amemiya T, Andersson B, Sverker J, Björntorp P. 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:882-886.
33. Nelson DH, Murray DK, Brady RO. 1982 Dexamethasone-induced change in the sphingomyelin content of human polymorphonuclear leukocytes in vitro. J Clin Endocrinol Metab. 54:292-295.
34. Nelson DH, Murray DK. 1982 Dexamethasone increases the synthesis of sphingomyelin in 3T3-L1 cell membranes. Proc Natl Acad Sci USA. 79:6690-6692.
35. Murray DK, Ruhmann-Wennhold A, Nelson DH. 1979 Dexamethasone effect on the phospholipid content of isolated fat cell ghosts from adrenalectomized rats. Endocrinology. 105:774-777.
36. Kamada T, Otsuji S. 1983 Lower levels of erythrocyte membrane fluidity in diabetic patients. Diabetes. 32:585-591.
37. Watala C. 1993 Altered structural and dynamic properties of blood cell membranes in diabetes mellitus. Diabetic Med. 10:13-20.
38. Muller S, Ziegler O, Donner M, Drouin P, Stoltz JF. 1990 Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia. Atherosclerosis. 83:231-237.
39. Hrelia S, Lercker G, Biagi PL, et al. 1986 Effect of ethanol intake on human erythrocyte membrane fluidity and lipid composition. Biochem Int. 12:741-750.
40. Neufeld ND, Ezrin C, Corbo L, Long D, Bush MA. 1986 Effects of caloric restriction and exercise on insulin receptors in obesity: association with changes in membrane lipids. Metabolism. 35:580-587.
41. Ginsberg BH, Brown TJ, Simon I, Spector AA. 1981 Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes. 30:773-781.
42. Bruneau C, Staedel-Flaig C, Crémel G, Leray C, Beck JP, Hubert P. 1987 Influence of lipid environment on insulin binding in cultured hepatoma cells. Biochim Biophys Acta. 928:287-296.
43. Berlin E, Bhathena SJ, Judd JT, Nair PP, Jones DY, Taylor PR. 1989 Dietary fat and hormonal effects on erythrocytes membrane fluidity and lipid composition in adult women. Metabolism. 38:790-796.
44. Dawson MC, Hemington N, Irvine RF. 1985 The inhibition of diacylglycerol-stimulated intracellular phospholipases by phospholipids with a phosphocholine-containing polar group. Biochem J. 230:61-68.
45. Sandra A, Fyler DJ, Marshall SJ. 1984 Effects of lipids on the transport activity of the reconstituted glucose transport system from rat adipocyte. Biochim Biophys Acta. 778:511-515.
46. Nelson DH, Murray DK. 1986 Sphingolipids inhibit insulin and phorbol ester stimulated uptake of 2-deoxyglucose. Biochem Biophys Res Commun. 138:463-467.
47. Arnold RS, Newton AC. 1991 Inhibition of the insulin receptor tyrosine kinase by sphingosine. Biochemistry. 30:7747-7754.
48. Hannun YA, Loomis CR, Merrill AH, Bell RM. 1986 Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem. 261:12604-12609.
49. Turinsky J, O'Sullivan DM, Bayly BP. 1990 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem. 265:16880-16885.
50. Yang Z, Costanzo M, Golde DW, Kolesnick RN. 1993 Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kB translocation in intact HL-60 cells. J Biol Chem. 268:20520-20523.
51. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995 Increased adipose tisue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 95:2409-2415.
52. Kern PA, Saghizadeh M, Ong JM, Bosh RJ, Deem R, Simsolo RB. 1995 The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 95:2111-2119.
53. Abbott WGH, Lillioja S, Young AA, et al. 1987 Relationship between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes. 36:897-904.
54. Laws A, King AC, Haskell WL, Reaven GM. 1991 Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscler Thromb. 11:1636-1642.
55. Byrne CD, Wareham NJ, Brown DC, et al. 1994 Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia. 37:889-896.
56. Karhapää P, Malkki M, Laakso M. 1994 Isolated low HDL cholesterol. Diabetes. 43:411-417.
57. Laakso M. 1993 How good a marker is insulin level for insulin resistance? Am J Epidemiol. 137:959-965.
58. Hollenbeck C, Reaven GM. 1987 Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 64:1169-1173.